EP3416672
ORITAVANCIN FORMULATIONS
:
EP einkaleyfi: Þýðing ekki lögð inn:
17.2.2017:
23.10.2024:
17753910.3
:
16.2.2037
:
ORITAVANCIN FORMULATIONS
17.2.2017
23.10.2024
:
Melinta Therapeutics, LLC:
389 Interpace Parkway Suite 450, Parsippany, NJ 07054, US
:
GRIFFITH, David, C.:
Parsippany NJ 07054, US
:
FAR, Adel, Rafai:
Parsippany NJ 07054, US
:
LEHOUX, Dario:
Parsippany NJ 07054, US
:
KRISHNA, Gopal:
Parsippany NJ 07054, US
:
201662296989 P:
18.2.2016:
US
:
US2017018340:
17.2.2017
:
A61K 38/14, A61K 47/40, A61P 31/04